<DOC>
	<DOCNO>NCT00288288</DOCNO>
	<brief_summary>The primary purpose study compare time , risk cost saving 2 patient group receive FDA approve leave ventricular pacing lead .</brief_summary>
	<brief_title>Prospective Registry Epicardial LV Leads Placed During Cardiac Surgery Procedures</brief_title>
	<detailed_description>The purpose study : ) examine usefulness place epicardial LV lead time open chest surgery patient likely benefit CRT system follow surgery ; b ) compare difference patient receive LV lead use transvenous approach patient receive LV lead use epicardial approach ; c ) ass cost effectiveness place LV lead via transvenous versus epicardial approach .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Left ventricular ejection fraction &lt; = 35 % 2 . QRS duration great = 120ms 3 . NYHA Functional Class 3 4 4 . Age &gt; = 18 year 1 . No previous pacemaker ICD implant 2 . No permanent atrial fibrillation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>